AUPH实时信号 | 通过Getagraph.com最大化利润

购买 107685 min ago

@ $7.86

发出时间: 15 Feb 2024 @ 02:50

回报率: -36.60%

上一信号: Feb 14 - 22:30

上一信号: 出售

回报率: -1.44 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 21:35):

Stats
今日成交量	18 248.00
平均成交量	2.09M
市值	720.20M
EPS	$0 ( 2024-02-15 )
下一个收益日期	( $-0.170 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.22
ATR14	$0.00700 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Greenleaf Peter	Sell	126 981	Common Stock
2024-03-06	Miller Joseph M	Sell	34 811	Common Stock
2024-03-06	Donley Matthew Maxwell	Sell	40 665	Common Stock
2024-03-06	Habig Scott Michael	Sell	17 777	Common Stock
2024-03-06	Robertson Stephen P.	Sell	57 745	Common Stock

INSIDER POWER
72.27
Last 95 transactions
Buy: 5 896 445 \| Sell: 560 044

音量相关性

長: -0.20 (neutral)

短: -0.61 (weak negative)

Signal:(70.639) Neutral

Aurinia Pharmaceuticals 相关性

10 最正相关
AVAC	0.953
HWEL	0.948
CIIG	0.947
AVEO	0.938
ARIZ	0.937
KVSA	0.934
FNVT	0.934
GRIL	0.932
GLLI	0.932
EMLD	0.93

10 最负相关
GRIN	-0.949
LGHL	-0.948
VIEW	-0.945
TIVC	-0.939
BNTX	-0.937
XFOR	-0.931
VORB	-0.93
CUTR	-0.93
THTX	-0.927
LQDT	-0.925

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Aurinia Pharmaceuticals 相关性 - 货币/商品

-0.71
( moderate negative )

-0.74
( moderate negative )

0.00
( neutral )

0.30
( neutral )

0.49
( neutral )

Aurinia Pharmaceuticals 财务报表

Annual	2023
营收:	$175.51M
毛利润:	$161.37M (91.94 %)
EPS:	$-0.540

FY	2023
营收:	$175.51M
毛利润:	$161.37M (91.94 %)
EPS:	$-0.540

FY	2022
营收:	$134.03M
毛利润:	$128.37M (95.77 %)
EPS:	$-0.760

FY	2021
营收:	$45.61M
毛利润:	$44.51M (97.61 %)
EPS:	$-1.400

Financial Reports:

No articles found.

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

实时更新： Aurinia Pharmaceuticals [AUPH]

Upcoming Earnings Alert